BIOMAT Database Logo BIOMAT Database Logo

Fluoxetine augmentation of haloperidol in chronic schizophrenia. 2003

Joo-Cheol Shim, and Deanna L Kelly, and Young-Hoon Kim, and Young-Ran Yoon, and Jeong-Hwan Park, and Jae-Gook Shin, and Robert R Conley

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D005260 Female Females
D005473 Fluoxetine The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants. Fluoxetin,Fluoxetine Hydrochloride,Lilly-110140,N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine,Prozac,Sarafem,Lilly 110140,Lilly110140
D006220 Haloperidol A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279) Haldol
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder

Related Publications

Joo-Cheol Shim, and Deanna L Kelly, and Young-Hoon Kim, and Young-Ran Yoon, and Jeong-Hwan Park, and Jae-Gook Shin, and Robert R Conley
Reply to Dr. J-C Shim and colleagues regarding "Fluoxetine augmentation of haloperidol in chronic schizophrenia" [J Clin Psychopharmacol 2003;23:520-521].
December 2004, Journal of clinical psychopharmacology,
Joo-Cheol Shim, and Deanna L Kelly, and Young-Hoon Kim, and Young-Ran Yoon, and Jeong-Hwan Park, and Jae-Gook Shin, and Robert R Conley
Fluoxetine in chronic schizophrenia.
February 1990, Journal of clinical psychopharmacology,
Joo-Cheol Shim, and Deanna L Kelly, and Young-Hoon Kim, and Young-Ran Yoon, and Jeong-Hwan Park, and Jae-Gook Shin, and Robert R Conley
Fluoxetine augmentation of clozapine treatment in patients with schizophrenia.
December 1996, The American journal of psychiatry,
Joo-Cheol Shim, and Deanna L Kelly, and Young-Hoon Kim, and Young-Ran Yoon, and Jeong-Hwan Park, and Jae-Gook Shin, and Robert R Conley
High dosage haloperidol in chronic schizophrenia.
September 1977, The British journal of psychiatry : the journal of mental science,
Joo-Cheol Shim, and Deanna L Kelly, and Young-Hoon Kim, and Young-Ran Yoon, and Jeong-Hwan Park, and Jae-Gook Shin, and Robert R Conley
Haloperidol, clopenthixol, and chlorpromazine in chronic schizophrenia.
November 1972, The Journal of nervous and mental disease,
Joo-Cheol Shim, and Deanna L Kelly, and Young-Hoon Kim, and Young-Ran Yoon, and Jeong-Hwan Park, and Jae-Gook Shin, and Robert R Conley
Predicting haloperidol treatment response in chronic schizophrenia.
August 1996, Psychiatry research,
Joo-Cheol Shim, and Deanna L Kelly, and Young-Hoon Kim, and Young-Ran Yoon, and Jeong-Hwan Park, and Jae-Gook Shin, and Robert R Conley
Haloperidol: a controlled trial in chronic schizophrenia.
January 1962, The Journal of mental science,
Joo-Cheol Shim, and Deanna L Kelly, and Young-Hoon Kim, and Young-Ran Yoon, and Jeong-Hwan Park, and Jae-Gook Shin, and Robert R Conley
A controlled study of haloperidol in chronic schizophrenia.
August 1967, Current therapeutic research, clinical and experimental,
Joo-Cheol Shim, and Deanna L Kelly, and Young-Hoon Kim, and Young-Ran Yoon, and Jeong-Hwan Park, and Jae-Gook Shin, and Robert R Conley
Neuroendocrine effects of haloperidol therapy in chronic schizophrenia.
October 1975, Psychopharmacologia,
Joo-Cheol Shim, and Deanna L Kelly, and Young-Hoon Kim, and Young-Ran Yoon, and Jeong-Hwan Park, and Jae-Gook Shin, and Robert R Conley
Adjunctive fluoxetine improves global function in chronic schizophrenia.
January 1990, The Journal of neuropsychiatry and clinical neurosciences,
Copied contents to your clipboard!